8-KThe WireRoutine
Bylaw Amendment · Shareholder Vote
Filed Jun 10, 2026 · 20d ago · Accession 0001193125-26-264085
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- 8-K
- Filing date
- Jun 10, 2026
- Report date
- Jun 9, 2026
- Document
- d152745d8k.htm
- Size
- 200 KB